Form 4 for WHWK Whitehawk Therapeutics, Inc.
Accepted 2024-05-01 00:00:00 ET · period of report 2024-05-01 · accession 0001415889-24-011937 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-05-01 | 2024-05-01 | WHWK | Desai Neil | EXECUTIVE COB, Dir | S - Sale | $1.93 | -40.0K | 1.33M | -3% | -$77.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-01 | S | D | 40,000 | $1.93 | 1,331,543 | I See footnote | — | — | (F2) Represents the weighted average share price of an aggregate total of 40,000 shares sold in the price range of $1.885 to $1.975 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. (F3) Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust. |